Pfizer se recusa a compartilhar a Paxlovid com a DNDi

Published June 2, 2022 | Version v1

Journal article Open

Aborda o caso no qual a Pfizer se recusara a compartilhar a Paxlovid com a DNDi

Files

Name	Size
Boletín Fármacos - PT-BR (1) (2).pdf md5:eed871d58c2ee5214ed1607abcaa2ec2	1.2 MB	Preview Download

Views

Downloads

Show more details

DOI

Resource type

Journal article

Publisher

Zenodo

Published in

Boletim Fármacos: Ensaios Clínicos, 25(2), 5, 2022.

License: Creative Commons Attribution 4.0 International

The Creative Commons Attribution license allows re-distribution and re-use of a licensed work on the condition that the creator is appropriately credited. Read more